Viatris Inc. (VTRS) Revenue Growth
Viatris Inc. (VTRS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 113.67% |
| 2018-12-31 | -4.08% |
| 2019-12-31 | -49.92% |
| 2020-12-31 | 3.95% |
| 2021-12-31 | 50.71% |
| 2022-12-31 | -8.96% |
| 2023-12-31 | -5.12% |
| 2024-12-31 | -4.52% |
| 2025-12-31 | -3.01% |
How VTRS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BMY | Bristol-Myers Squibb Company | -0.22% |
| AMPH | Amphastar Pharmaceuticals Inc. | -1.65% |
| QDEL | QuidelOrtho Corp Com | -1.89% |
| HAE | Haemonetics Corporation | -1.97% |
| NRC | National Research Corporation | -3.96% |
These are five companies in the same sector as VTRS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Viatris Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("VTRS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VTRS | $16.88 | -0.35% | 5.60M |
| 3 | ||||
| 4 | ||||
| 5 |